` 600993 (Mayinglong Pharmaceutical Group Co Ltd) vs NOVO B (Novo Nordisk A/S) Comparison - Alpha Spread

M
600993
vs
NOVO B

Over the past 12 months, Mayinglong Pharmaceutical Group Co Ltd has significantly outperformed NOVO B, delivering a return of +8% compared to the NOVO B's 55% drop.

Smart Verdict
AI-Powered

Not Sure Which Stock Wins?
Let AI Decide.
600993
NOVO B
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Valuation
Growth
Profitability
Solvency
Comparing Valuation
Running a multi-layered valuation analysis to compare how attractive each stock is.
Comparing Growth
Financial growth, forecasts, volatility, and historical drawdowns.
Comparing Profitability
Margins, returns on capital, and the consistency of profitability.
Comparing Solvency
Debt levels, liquidity, interest coverage, and bankruptcy risk.
Summarizing...
We need a little more time to summarize the results

Valuation Comparison

M
Intrinsic Value
35.34 CNY
Undervaluation 21%
Intrinsic Value
Price
NOVO B Intrinsic Value
630.43 DKK
Undervaluation 30%
Intrinsic Value
Price
Company Last Price Intrinsic Value DCF Value Relative Value Wall St Target
M
Mayinglong Pharmaceutical Group Co Ltd
SSE:600993
27.92 CNY
Novo Nordisk A/S
CSE:NOVO B
441.75 DKK
Valuation Scenario:
Bear Case
Base Case
Bull Case

Growth Comparison

Growth Over Time
600993 vs NOVO B

600993
NOVO B
Add Stock
Revenue
www.alphaspread.com
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
M
Mayinglong Pharmaceutical Group Co Ltd
Revenue
Novo Nordisk A/S
Revenue

All metrics are calculated based on data from the last 10 years.

Profitability Comparison

Free Cash Flow
600993 vs NOVO B

600993
NOVO B
Add Stock
Free Cash Flow
www.alphaspread.com
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
M
Mayinglong Pharmaceutical Group Co Ltd
SSE:600993
Novo Nordisk A/S
CSE:NOVO B
What is Free Cash Flow?

Gross Margin

Mayinglong Pharmaceutical Group Co Ltd
46.1%
NOVO B
84.3%

Operating Margin

Mayinglong Pharmaceutical Group Co Ltd
16.2%
NOVO B
44.6%

Net Margin

Mayinglong Pharmaceutical Group Co Ltd
14.3%
NOVO B
34.5%

FCF Margin

Mayinglong Pharmaceutical Group Co Ltd
10.5%
NOVO B
24.5%

ROE

Mayinglong Pharmaceutical Group Co Ltd
13.4%
NOVO B
88.1%

ROA

Mayinglong Pharmaceutical Group Co Ltd
10.5%
NOVO B
26.6%

ROIC

Mayinglong Pharmaceutical Group Co Ltd
27.1%
NOVO B
30.4%

ROCE

Mayinglong Pharmaceutical Group Co Ltd
14%
NOVO B
70%

Solvency Comparison

Balance Sheet Comparison

Stocks Performance

Stocks Performance
600993 vs NOVO B

Loading
600993
NOVO B
Add Stock
www.alphaspread.com

Performance Gap
600993 vs NOVO B

Loading
600993
NOVO B
Difference
www.alphaspread.com

Performance By Year
600993 vs NOVO B

Loading
600993
NOVO B
Add Stock
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Compare 600993 to other stocks
Unlock Full Access to Alpha Spread
Create Free Account